Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NSD2 | O96028 | 1/20 | 0.42 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.35 |
| ▸ | GRM4 | Q14833 | 7/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.33 |
| ▸ | GRM8 | O00222 | 3/20 | 0.33 |
| ▸ | GRM6 | O15303 | 3/20 | 0.33 |
| ▸ | GRM2 | Q14416 | 3/20 | 0.33 |
| ▸ | GRM3 | Q14832 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | GRM5 | P41594 | 1/20 | 0.33 |
| ▸ | MTOR | P42345 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27709210 | 0.97 | NSD2 (0.40) | NSD2FFAR3GRM4CYP1A2CYP2C19 | |
| SCHEMBL7217948 | 0.95 | NSD2 (0.39) | NSD2FFAR3GRM4CYP1A2CYP2C19 | |
| SCHEMBL27387014 | 0.83 | NSD2 (0.39) | NSD2FFAR3GRM4CYP1A2CYP2C19 | |
| SCHEMBL28254635 | 0.83 | NSD2 (0.39) | NSD2FFAR3GRM4CYP1A2CYP2C19 | |
| Hydrochloric Acid SCHEMBL3142298 | 0.77 | FFAR3 (0.44) | NSD2FFAR3CYP2C19LMNA | |
| SCHEMBL204371 | 0.77 | FFAR3 (0.44) | NSD2FFAR3CYP2C19LMNA | |
| Hydrochloric Acid SCHEMBL628949 | 0.77 | FFAR3 (0.44) | NSD2FFAR3CYP2C19LMNA | |
| SCHEMBL4312696 | 0.72 | — | — | |
| 1-Aminocyclopropane Carboxylic Acid SCHEMBL1320265 | 0.69 | — | — | |
| SCHEMBL7159924 | 0.67 | NSD2 (0.34) | NSD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8354512-B2 | Ligand and metal complex | NATIONAL CHIAO TUNG UNIVERSITY (TW) | 2013-01-15 | — | — | US | disclosed |
| US-20110065905-A1 | Ligand and metal complex | NATIONAL CHIAO TUNG UNIVERSITY (TW) | 2011-03-17 | — | — | US | disclosed |
| CN-101385705-A | Preparation method of aqueouse solution agent of minoplatin and other platinum complexes | QIANHUAN DAI (CN) | 2009-03-18 | — | — | CN | disclosed |
| WO-2008144616-A1 | LIPID RAFT, CAVEOLIN PROTEIN, AND CAVEOLAR FUNCTION MODULATION COMPOUNDS AND ASSOCIATED SYNTHETIC AND THERAPEUTIC METHODS | KAY HEIDI (US) | 2008-11-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110065905-A1 | Ligand and metal complex | CD74, SLC39A14, PYM1 | NSD2 3731/4885FFAR3 2743/4885GRM4 207/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.